基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Greco Theresa. Insider active across 1 company, notably OptimizeRx Corp. Cumulatively, 7 reports have been published. Activity tracked since 1 November 2023. The latest transaction was filed on 23 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Greco Theresa is a declarant connected to OptimizeRx Corp, where she is Chief Commercial Officer. She has 4 filings in total, and across the sampled recent filings from 2023-11-03 to 2025-05-19, the modal transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.